Wilshire Advisors LLC
- SEC CIK
- 0001616628
- Latest filing
- Jul 27, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 9
- 0 vs. Q2 2021
- Portfolio value
- $37.6M
- −$1.53M (−3.9%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| iShares Core MSCI Eafe ETF46432F842 | ETF | 107,100 | $7.95M | 21.2% | −911−0.8% | Reduced | – |
| iShares Core MSCI Emerging Markets ETF46434G103 | ETF | 88,620 | $5.47M | 14.6% | +4,578+5.4% | Added | – |
| Vanguard Total International Bond ETF92203J407 | ETF | 92,400 | $5.26M | 14.0% | +173+0.2% | Added | – |
| iShares Tr46432F859 | CORE 1 5 YR USD | 101,857 | $5.20M | 13.9% | +101,857 | New | – |
| iShares Tr464288117 | INTL TREA BD ETF | 100,183 | $5.14M | 13.7% | +1,137+1.1% | Added | – |
| iShares Tr464288877 | EAFE VALUE ETF | 67,380 | $3.43M | 9.1% | −7,857−10.4% | Reduced | – |
| iShares Core S&P Small Cap ETF464287804 | ETF | 28,473 | $3.11M | 8.3% | +659+2.4% | Added | – |
| Vanguard Emerging Markets Government Bond ETF921946885 | ETF | 22,290 | $1.75M | 4.6% | −10,736−32.5% | Reduced | – |
| FATEFate Therapeutics Inc | COM | 4,083 | $242.0K | 0.6% | +4,083 | New | History |
Sold out since Q2 2021 (2)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| iShares Tr464288646 | ISHS 1-5YR INVS | 57,327 | $3.14M | 8.0% | – |
| iShares Tr46434V613 | CORE UNIVRSL USD | 39,457 | $2.11M | 5.4% | – |